Relmada Therapeutics (RLMD) Stock Chart & Stock Price History → Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (From InvestorPlace) (Ad) Free RLMD Stock Alerts $3.00 -0.04 (-1.32%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Relmada Therapeutics Stock Price Performance5 Day Performance+1.69%1 Month Performance-19.35%3 Month Performance-55.88%6 Month Performance+19.52%Year-To-Date Performance-27.54%1 Year Performance+6.01% Receive RLMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. RLMD Stock Chart for Sunday, June, 2, 2024 RLMD Chart by TradingView Relmada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.04$3.00-1.32%$3.16$2.9563,625 shs$90.51 million05/30/2024$2.93$3.04+3.75%$3.16$2.91129,477 shs$91.73 million05/29/2024$2.95$2.93-0.68%$3.00$2.9026,453 shs$88.40 million05/28/2024$3.05$2.95-3.28%$3.12$2.8665,141 shs$89.00 million05/27/2024$3.05$3.05$3.12$2.9692,000 shs$92.02 million05/24/2024$3.11$3.05-1.93%$3.12$2.9692,014 shs$92.02 million Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$3.09$3.11+0.65%$3.15$2.94119,724 shs$93.83 million05/22/2024$3.24$3.09-4.63%$3.27$3.09167,248 shs$93.23 million05/21/2024$3.24$3.24$3.35$3.13143,548 shs$97.75 million05/20/2024$3.34$3.24-2.99%$3.44$3.2463,318 shs$97.76 million05/17/2024$3.49$3.34-4.30%$3.50$3.3246,958 shs$100.77 million05/16/2024$3.48$3.49+0.29%$3.55$3.4643,530 shs$105.31 million05/15/2024$3.64$3.48-4.40%$3.75$3.4667,460 shs$104.99 million05/14/2024$3.53$3.64+3.12%$3.72$3.47100,042 shs$109.82 million05/13/2024$3.53$3.53$3.69$3.5058,248 shs$106.50 million05/10/2024$3.80$3.53-7.11%$3.88$3.5379,440 shs$106.50 million05/09/2024$3.83$3.80-0.78%$4.00$3.68101,030 shs$114.65 million05/08/2024$3.82$3.83+0.26%$3.95$3.7552,698 shs$115.55 million05/07/2024$3.85$3.82-0.78%$3.88$3.7765,817 shs$115.25 million05/06/2024$3.68$3.85+4.62%$4.00$3.6682,031 shs$116.17 million05/03/2024$3.72$3.68-1.08%$3.93$3.6392,858 shs$111.03 million05/02/2024$3.69$3.72+0.81%$3.78$3.7021,845 shs$112.23 million05/01/2024$3.64$3.69+1.37%$3.83$3.6264,008 shs$111.34 million04/30/2024$3.53$3.64+3.12%$3.74$3.46147,724 shs$109.82 million04/29/2024$3.83$3.53-7.83%$3.97$3.35241,668 shs$106.50 million04/26/2024$3.70$3.83+3.51%$3.87$3.6280,013 shs$115.55 million04/25/2024$3.86$3.70-4.15%$3.81$3.6685,873 shs$111.63 million04/24/2024$3.91$3.86-1.28%$3.96$3.75114,585 shs$116.46 million04/23/2024$3.87$3.91+1.03%$4.10$3.82143,632 shs$117.97 million04/22/2024$4.00$3.87-3.25%$4.06$3.70178,113 shs$116.76 million04/19/2024$4.30$4.00-6.98%$4.31$3.95152,611 shs$120.68 million04/18/2024$4.68$4.30-8.12%$4.72$4.2786,188 shs$129.73 million04/17/2024$4.56$4.68+2.63%$4.72$4.5285,164 shs$141.21 million04/16/2024$4.45$4.56+2.47%$4.61$4.3263,203 shs$137.58 million04/15/2024$4.65$4.45-4.30%$4.73$4.41125,022 shs$134.26 million04/12/2024$4.66$4.65-0.21%$4.68$4.54120,024 shs$140.29 million04/11/2024$4.51$4.66+3.33%$4.81$4.50116,844 shs$140.59 million04/10/2024$4.80$4.51-6.04%$4.90$4.29158,446 shs$136.07 million04/09/2024$4.86$4.80-1.23%$5.09$4.7587,723 shs$144.82 million04/08/2024$4.59$4.86+5.88%$4.97$4.6463,172 shs$146.63 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$4.69$4.59-2.13%$4.84$4.53101,079 shs$138.48 million04/04/2024$4.71$4.69-0.42%$5.02$4.66178,512 shs$141.50 million04/03/2024$4.94$4.71-4.66%$5.09$4.68144,674 shs$142.10 million04/02/2024$4.88$4.94+1.23%$5.05$4.79136,589 shs$149.04 million04/01/2024$4.65$4.88+4.95%$5.00$4.60126,543 shs$147.23 million03/29/2024$4.65$4.65$4.71$4.50113,420 shs$140.29 million03/28/2024$4.59$4.65+1.31%$4.71$4.50113,100 shs$140.29 million03/27/2024$4.69$4.59-2.13%$4.82$4.40149,749 shs$138.48 million03/26/2024$4.90$4.69-4.29%$5.00$4.64103,407 shs$141.50 million03/25/2024$4.86$4.90+0.82%$5.13$4.68271,595 shs$147.83 million03/22/2024$4.66$4.86+4.29%$4.96$4.54267,508 shs$146.63 million03/21/2024$4.44$4.66+5.07%$4.66$3.99651,733 shs$140.27 million03/20/2024$5.37$4.44-17.41%$5.66$4.34687,629 shs$133.49 million03/19/2024$5.52$5.37-2.72%$5.84$5.36229,147 shs$161.64 million03/18/2024$5.42$5.52+1.85%$5.73$5.50123,586 shs$166.15 million03/15/2024$5.03$5.42+7.75%$5.53$4.80194,504 shs$163.14 million03/14/2024$5.64$5.03-10.82%$5.52$4.93163,092 shs$151.40 million03/13/2024$5.53$5.64+1.99%$5.76$5.57127,336 shs$169.76 million03/12/2024$5.77$5.53-4.16%$5.97$5.35221,233 shs$166.45 million03/11/2024$6.35$5.77-9.13%$6.38$5.76164,282 shs$173.68 million03/08/2024$6.37$6.35-0.31%$6.55$6.16119,024 shs$191.14 million03/07/2024$6.40$6.37-0.47%$6.63$6.16138,889 shs$191.74 million03/06/2024$6.32$6.40+1.27%$6.57$6.26101,383 shs$192.64 million03/05/2024$6.35$6.32-0.47%$6.49$6.2685,856 shs$190.23 million03/04/2024$6.80$6.35-6.62%$7.22$6.27245,825 shs$191.14 million03/01/2024$6.13$6.80+11.02%$6.87$6.12512,746 shs$204.68 million Related Companies: Verrica Pharmaceuticals Stock Price Chart Shattuck Labs Stock Price Chart AC Immune Stock Price Chart Organogenesis Stock Price Chart Amarin Stock Price Chart Alto Neuroscience Stock Price Chart Precigen Stock Price Chart Skye Bioscience Stock Price Chart Silverback Therapeutics Stock Price Chart Nkarta Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.